Literature DB >> 1710193

Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.

T Okuno1, M Shindo, K Arai, M Matsumoto, M Takeda, K Kashima, Y Sokawa.   

Abstract

We measured the sequential changes in 2',5' oligoadenylate synthetase activity in 21 patients with acute viral hepatitis (5 with type A, 6 with type B, and 10 with type non-A, non-B hepatitis) by radioimmunoassay. Liver biopsies were performed during the acute phase in all patients. Among patients with acute hepatitis A and B, the 2',5' oligoadenylate synthetase levels were transiently elevated at the time of the peak alanine aminotransferase level in the patients in whom a liver biopsy showed acute hepatitis or non-specific reactive hepatitis. Of 10 patients with acute non-A, non-B hepatitis, 4 showed a similar 2',5' oligoadenylate synthetase activity pattern and liver histology to those observed in acute hepatitis A and B. In the remaining 6, the 2',5' oligoadenylate synthetase levels remained elevated for 3.5 to 6 months while the alanine aminotransferase was elevated. Liver biopsy in these patients showed chronic hepatitis. Persistent detection of raised 2',5' oligoadenylate synthetase activity levels during the acute stage of non-A, non-B hepatitis may thus be an indicator of progression of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710193     DOI: 10.1007/bf02811075

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  22 in total

1.  Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.

Authors:  M Shindo; T Okuno; M Matsumoto; M Takeda; T Takino; J Sokawa; A Iwata; Y Sokawa
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

2.  Absence of circulating interferon in patients with infectious and serum hepatitis.

Authors:  E F Wheelock; S Schenker; B Combes
Journal:  Proc Soc Exp Biol Med       Date:  1968-05

3.  Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis.

Authors:  D A Hill; J H Walsh; R H Purcell
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

4.  Interferon system in acute viral hepatitis.

Authors:  S Levin; T Hahn
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

5.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C M Chu; I J Su; M J Huang; D Y Lin; C S Chang-Chien
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

6.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

7.  Decreased interferon response by lymphocytes from children with chronic hepatitis.

Authors:  P Tolentino; F Dianzani; M Zucca; R Giacchino
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

8.  Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. A clinicopathological study.

Authors:  Y F Liaw; S S Yang; T J Chen; C M Chu
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.

Authors:  G Realdi; A Alberti; M Rugge; A M Rigoli; F Tremolada; L Schivazappa; A Ruol
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.